AXIAL Logo 2021MAR05.png
Axial Therapeutics to Present at Upcoming Conferences
05. Januar 2024 08:05 ET | Axial Therapeutics
WOBURN, Mass., Jan. 05, 2024 (GLOBE NEWSWIRE) -- Axial Therapeutics, a clinical-stage biotechnology company dedicated to the development of gut-targeted, small molecule therapeutics for neurological...
AXIAL Logo 2021MAR05.png
Axial Therapeutics Announces Key Research and Development Promotions to Advance Clinical and Preclinical Pipeline of Small Molecule Microbiome Therapeutics
29. März 2023 08:00 ET | Axial Therapeutics
– Phase 2b clinical trial for AB-2004 in autism irritability ongoing and enrollment anticipated to be complete by end of 2023 – – IND-enabling studies ongoing for Parkinson’s Disease development...
TIP_link_300x300.jpg
Industrial Fans Market Size to Hit $12.64 Billion by 2028, Globally, Driven by Major Technological Advancements – Growth Report by The Insight Partners
31. Januar 2023 10:04 ET | The Insight Partners
New York, Jan. 31, 2023 (GLOBE NEWSWIRE) -- According to The Insight Partners; “Industrial Fans Market Size, Share, Growth, Trends and Global Forecast to 2028 - COVID-19 Impact and Global Analysis...
AXIAL Logo 2021MAR05.png
Axial Therapeutics CEO A. Stewart Campbell to Present at Microbiome Connect: USA 2022
01. November 2022 08:00 ET | Axial Therapeutics
WOBURN, Mass., Nov. 01, 2022 (GLOBE NEWSWIRE) -- Axial Therapeutics, a clinical-stage biopharmaceutical company dedicated to the development of gut-targeted, small molecule therapeutics for...
AXIAL Logo 2021MAR05.png
Axial Therapeutics Expands Clinical Development Capabilities with Key Appointments
11. Oktober 2022 08:00 ET | Axial Therapeutics
- Clinical development operations focused on ongoing Phase 2b clinical trial of AB-2004 in autism; data anticipated in 2023 - - Team also supporting additional microbiome-based small molecule...
AXIAL Logo 2021MAR05.png
Axial Therapeutics to Present at BioJapan Conference
06. Oktober 2022 08:00 ET | Axial Therapeutics
WOBURN, Mass., Oct. 06, 2022 (GLOBE NEWSWIRE) -- Axial Therapeutics Inc., a clinical-stage biopharmaceutical company dedicated to the development of gut-targeted, small molecule therapeutics for...
TECATverticalLogo.jpg
Businesses Distress During Pandemic, but TECAT Performance Systems Grows
01. August 2022 06:00 ET | TECAT Performance Systems
ANN ARBOR, Mich., Aug. 01, 2022 (GLOBE NEWSWIRE) -- TECAT Performance Systems today announces a new online store to supplement the strength of its product and accessories offerings. A clear sign of...
TECATverticalLogo.jpg
TECAT Announces New Patent for Integrated Wireless Data System and Method for Pump Control
19. Oktober 2021 07:00 ET | TECAT Performance Systems
ANN ARBOR, Mich., Oct. 19, 2021 (GLOBE NEWSWIRE) -- TECAT Performance Systems today announces a new patent for an integrated wireless data system and method for pumpjack control. It is the second...